1308672-74-3Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1TTZSNFLLYPYKIL-UHFFFAOYSA-NSurufatinib is under investigation in clinical trial NCT02588170 (Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors).
1308672-74-3CHEMBL4297190안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
L - Antineoplastic and immunomodulating agents
QL - Antineoplastic and immunomodulating agents
용도Sulfatinib is used in pharmaceutical compositions comprising of micronized drug.
불러오는 중…
불러오는 중…
불러오는 중…